Paola Rogliani on Muck Rack

Paola Rogliani

United Kingdom
As seen in: touchRESPIRATORY, MDPI, Taylor & Francis Online, The Lancet, Dove Medical Press, European Respiratory Journal, European Respiratory Review, Chest, The Journal of Allergy & Clinical Immunology, Annals of Allergy, Asthma & Immunology, Respiratory Medicine and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Paola

Contact Paola, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Exploring AI and ML in managing overlap between cardiovascular disease and asthma or COPD: a scoping review

|
By Luigino Calzetta, Mario Cazzola, Elena Pistocchini, Shima Gholamalishahi, Rossella Laitano, Paola Rogliani
| Respiratory Medicine Verified
Keywords Asthma Artificial Intelligence Comorbidity COPD CVD Machine Learning Get full text access Log in, subscribe or purchase for full access. References 1. Rogliani, P. ∙ Ora, J. ∙ Calzetta, L. ... Asthma and comorbidities: recent advances, Pol Arch. Intern. Med. 2022; 132 2. Yuan, L. ∙ Tao, J. ∙ Wang, J. ... Global, regional, national burden of asthma from 1990 to 2021, with projections of incidence to 2050: a systematic analysis of the global burden of disease study 2021 EClinicalMedicine. 2025; 80 3.
Open in Who Shared Issue with article?

BDP/FF/GB single-inhaler triple therapy in COPD: real-world effectiveness, safety, and adherence in a pooled analysis of 5,000 patients

|
By Guy G. Brusselle, Elena Nudo, Laura Franzini, Petros Bakakos, Daiana Stolz, Alessio Piraino, Luca Di Palma, Paola Rogliani, Laura Franzini
| Respiratory Medicine Verified
Keywords COPD Single-inhaler triple therapy Extrafine BDP/FF/GB CAT score Exacerbation Adherence Get full text access Log in, subscribe or purchase for full access. References 3. Adeloye, D. ∙ Song, P. ∙ Zhu, Y. ... Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis The Lancet Respiratory Medicine. 2022; 10(5):447-458 4. Al Wachami, N. ∙ Guennouni, M. ∙ Iderdar, Y. ...
Open in Who Shared Issue with article?

Efficacy of tezepelumab in reducing oral corticosteroid use in severe asthma

|
By Paola Rogliani
| The Lancet Verified
FREE with registration! Log in or register to access the full article. References 1. Gyawali, B ∙ Georas, SN ∙ Khurana, S Biologics in severe asthma: a state-of-the-art review Eur Respir Rev. 2025; 34:240088 2. Lanario, JW ∙ Cartwright, L ∙ Jones, RC ∙ et al. “Life-changing”: the experience of super-responders to biologics in severe asthma BMC Pulm Med. 2022; 22:445 3.
Open in Who Shared Issue with article?
See all 68 licensed articles (72 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified